prof. dr. E.G.E. (Elisabeth) de Vries


No picture available


  1. 2018
  2. Jalving, M., & de Vries, E. G. E. (2018). Immune Checkpoint Blockade: Response Patterns and Assessment of Response. In J. B. A. G. Haanen , R. Califano, I. Lugowska, & M. C. Garassino (Eds.), ESMO Handbook of Immuno-Oncology (1 ed., pp. 258-266). (ESMO Handbook Series). the European Society for Medical Oncology (ESMO).
  3. 2017
  4. Oosting, S. F., de Vries, E. G. E., & Witjes, M. (2017). Molecular Imaging in Head and Neck Squamous Cell Carcinoma Patients. In J. B. Vermorken, V. Budach, C. R. Leemans, J-P. Machiels, P. Nicolai, & B. O'Sullivan (Eds.), Critical Issues in Head and Neck Oncology: Key concepts from the Fifth THNO Meeting (pp. 77-96). Springer.
  5. 2015
  6. Koopmans, K. P., Dierckx, R., Elsinga, P. H., Links, T., Kema, I., Fiebrich, H. B., ... Brouwers, A. (2015). Other Radiopharmaceuticals for Imaging GEP‐NET. In A. Hubalewska‐Dydejczyk, A. Signore, M. de Jong, R. A. Dierckx, J. Buscombe, & C. Van de Wiele (Eds.), Somatostatin Analogues: From Research to Clinical Practice, 1 (pp. 75-85). John Wiley and Sons Inc..
  7. 2011
  8. Duiker, E. W., de Vries, E., Mahalingam, D., Meersma, G. J., Lub-de Hooge, M. N., Cool, R. H., ... de Jong, S. (2011). ENHANCED ANTI-TUMOR EFFICACY OF A DR5-SPECIFIC TRAIL VARIANT OVER RHTRAIL IN A BIOLUMINESCENT OVARIAN CANCER XENOGRAFT MODEL. In D. Wallach, A. Kovalenko, & M. Feldman (Eds.), ADVANCES IN TNF FAMILY RESEARCH (pp. 796-797). (Advances in Experimental Medicine and Biology; Vol. 691). BERLIN: Springer.
  9. 2010
  10. de Vries, E. G. E., Reyners, A. K. L., Schroder, C., Walenkamp, A., & Gietema, J. A. (2010). Oncologie. In CDA. Stehouwer, RP. Koopmans, & J. van der Meer (Eds.), Interne Geneeskunde Bohn, Stafleu, Van Loghum.
  11. 2007
  12. Schroder, C. P., Hospers, G. A. P., Willemse, P. H. B., Perik, P. J., de Vries, E. F. J., Jager, P. L., ... de Vries, E. G. E. (2007). Molecular imaging in metastatic breast cancer. In Cancer Metastasis – Biology and treatment: Volume 11: Metastasis of breast cancer (Vol. 11, pp. 307-319). Springer.
  13. 2005
  14. de Vries, E. G. E., Reyners, A. K. L., Rodenburg, CJ., Willemse, P., & Gietema, J. A. (2005). Oncologie. In J. van der Meer, & CDA. Stehouwer (Eds.), Interne Geneeskunde Bohn, Stafleu, Van Loghum.
  15. 2003
  16. Kleibeuker, JH., De Vries, EGE., & Van Der Meer, R. (2003). Calcium: a protective agent against colorectal cancer? In W. Scheppach, & M. Scheurlen (Eds.), EXOGENOUS FACTORS IN COLONIC CARCINOGENESIS (pp. 287-296). (FALK SYMPOSIUM; Vol. 128). DORDRECHT: Springer.
  17. 2000
  18. de Vries, EGE., & Rodenhuis, S. (2000). High-dose chemotherapy in breast cancer: In favor! In GR. DiPaola, & J. Sardi (Eds.), GYNECOLOGIC ONCOLOGY ISSUES IN THE 8TH IGCS MEETING OF BUENOS AIRES (pp. 31-34). 40128 BOLOGNA: MEDIMOND PUBLISHING CO.
  19. 1999
  20. Vellenga, E., Muller, M., & de Vries, EGE. (1999). Multidrug resistance protein MRP1, glutathione, and related enzymes - Their importance in acute myeloid leukemia. In GJL. Kaspers, R. Pieters, & AJP. Veerman (Eds.), DRUG RESISTANCE IN LEUKEMIA AND LYMPHOMA III (pp. 187-198). (ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY; Vol. 457). NEW YORK: Kluwer Academic/Plenum Publishers.
  21. 1998
  22. Schroder, CP., van der Graaf, WTA., Willemse, PHB., Vellenga, E., de Leij, L., Mulder, NH., & de Vries, EGE. (1998). The impact of haematopoietic growth factors on supportive care in clinical oncology: With special attention to potential tumour cell contamination in the stem cell harvest. In CTS. Sibinga, PC. Das, & JC. Fratantoni (Eds.), ALTERNATIVE APPROACHES TO HUMAN BLOOD RESOURCES IN CLINICAL PRACTICE (pp. 81-95). (DEVELOPMENTS IN HEMATOLOGY AND IMMUNOLOGY; Vol. 33). DORDRECHT: Springer.
  23. 1996
  24. VanderZee, AGJ., & DeVries, EGE. (1996). Drug resistance factors. In F. Sharp, T. Blackett, R. Leake, & J. Berek (Eds.), OVARIAN CANCER 4 (pp. 221-233). LONDON: Chapman & Hall.

ID: 162081